INS and type 2 diabetes mellitus: American Diabetes Association (ADA) have updated guidelines on use of the device, stating that for insulin–treated people with T2D who are not meeting glycaemic targets, intermittently scanned continuous glucose monitors can be used to lower HbA1c and/or reduce hypoglycaemia44.